Crowdonomics
All companies
Harmony Baby Nutrition logo

Harmony Baby Nutrition

Raising nowOperating

Milk Care Co., Inc.

Biotech · Natick, MA

Minority-founded
Visit website255 followers on WeFunder · as of Oct 9, 2026

Baby formulas inspired by human milk

Raising nowRaising now on WeFunder

This company has an open fundraising round.

$475K raised251 investors203 days left
View the live round
Valuation cap ⓘ
$35.0M
As of Oct 2025 · from Reg CF Offering (2025) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$474,904
Across 1 round since 2025

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$0
−$2.1M
2023
$0
−$2.4M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$2,116,836
-$2,411,594
Taxes paid
$0
$0
Balance sheet
Cash
$3,789,925
$1,613,138
Accounts receivable
$0
$0
Total assets
$4,050,283
$1,694,463
Short-term debt
$135,916
$152,112
Long-term debt
$0
$0
Total liabilities
$135,916
$152,112
Other
Headcount
—
4

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$35.0M
Valuation cap
Reg CF · SAFE · Oct 2025

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Cap table

Share counts as of Dec 31, 2025
Series Seed Preferred Stock · 40.5%Common Stock · 59.5%
ClassOutstandingVotes / shareShare of totalLast price
Series Seed Preferred Stockpreferred4,287,164—40.5%—
Common Stock6,305,972—59.5%—
Total10,593,136100%

Shares outstanding over timein today's share terms

6.3M3.2M0
Dec 2024Dec 2025
Common StockSeries Seed Preferred StockRound opened

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $474.9K / $2MInvestors 251Valuation cap $35M

Team

9 people
Wendel AfonsoFounder
Founder and CEO

Serial entrepreneur. Launched 30+ innovative nutrition products for thousands of babies as Founder of INVITA Specialized Nutrition, Deloitte #2 fastest growing SME in Brazil. Author of 30 publications & 7 patents. MIT Sloan MBA. UFMG Food Science MSc.

Ashley Ho
Founder and CEO
Priya Yadav
Vice President, Investments
Mariana Souza
VP, Formulation

Food scientist & infant nutrition expert. Launched 15+ clinical nutrition products end-to-end. Author of 18 scientific publications. Expertise in formulation, analytics, & bioactive optimization for probiotics & prebiotics. UFMG Food Science PhD.

Mauro Ramalho Silva
VP, Quality and Manufacturing

Manufacturing & quality control leader. Led infant formula from characterization to industrial scale across 13 innovation projects. University professor since 2016. Author of 78 scientific papers & 21 book chapters. UFMG Food Science PhD.

Shirley Szeto
Head of Business Strategy and Operations

Venture builder. Strategy & ops leader for early-stage science & nutrition startups. Led full-cycle VC investing for a $75M deep-tech fund. Experience building companies from 0 to launch. Chinese University of Hong Kong Global Economics & Finance BSc.

Dr. Robert DiGregorio, D.O.
Senior Regulatory Advisor

Physician & executive. 40 years in healthcare, including 19 in regulatory leadership at Wyeth, Pfizer, & Nestlé Nutrition. Expert in FDA strategy & clinical trial design. Philadelphia College of Osteopathic Medicine DO.

Dr. Victoria Mackenzie Martin, MD
Senior Medical Advisor

Pediatric gastroenterologist & food allergy expert. Co-Director, Pediatric GI Section, Food Allergy Center at Mass General Hospital for Children. Assistant Professor, Harvard Medical School. Harvard T.H. Chan MPH. UMass Chan Medical School MD.

Rini Greenfield
General Partner

Names and titles as disclosed on SEC Form C, WeFunder. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

251 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 29, 20260002086168-26-000004
    EDGAR
  • Form C/AMar 26, 20260002086168-26-000002
    EDGAR
  • Form C/AJan 16, 20260002086168-26-000001
    EDGAR
  • Form COct 8, 20250002086168-25-000001
    EDGAR
Source: SEC EDGARCIK 0002086168DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.